Ginsenoside Rk1
CAS No. 494753-69-4
Ginsenoside Rk1( —— )
Catalog No. M20267 CAS No. 494753-69-4
Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 85 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside Rk1
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
-
DescriptionGinsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
-
In VitroGinsenoside Rk1 (0-40 μM; 6 hours) inhibits MCP-1 and TNF-α mRNA induced by lipopolysaccharide (LPS), expression of IL-1β is inhibited at 40 μM.Ginsenoside Rk1 (0-40 μM; 24 hours) inhibits phosphorylation of JAK2 and STAT3 (Tyr705 and Ser727) in LPS-induced RAW264.7 cells in a dose-dependent manner.Ginsenoside Rk1 (0-160 μM; 48 hours) results in cell viability significant decrease 75.52 ± 2.51% (40 μM), 52.72 ± 2.54% (80 μM), 17.41 ± 2.94% (120 μM)and 12.63 ± 3.24% (160 μM) compared with control.Ginsenoside Rk1 (0-120 μM; 24 hours) increases G0/G1 phase proportion accompanied with S and G2/M phase proportion decrease in MDA-MB-231 cells.Ginsenoside Rk1 (0-120 μM; 24 hours) promotes the percentage of apoptotic cells in a dose-dependent manner, exhibits to reduction of cell number with nucleus fragmentation, condensation and apoptotic body formation. RT-PCR Cell Line:RAW264.7 cells Concentration:10 μM, 20 μM, 40 μM Incubation Time:6 hours Result: Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells.Western Blot Analysis Cell Line:RAW264.7 cells Concentration:10 μM, 20 μM, 40 μM Incubation Time:6 hours Result:Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells Cell Viability Assay Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:48 hours Result:Inhibited MDA-MB-231 cells proliferation in a dose- and time-dependent manner.Cell Cycle Analysis Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:24 hours Result:Induced G0/G1 phase arrest.Apoptosis Analysis Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:24 hours Result:Induced apoptosis in MDA-MB-231 cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number494753-69-4
-
Formula Weight767.01
-
Molecular FormulaC42H70O12
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (117.34 mM)
-
SMILES[H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)CC[C@@]3([H])C(C)(C)[C@H](CC[C@]3(C)[C@@]1([H])C[C@H]2O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=C)CC\C=C(/C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim JS et al. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch Pharm Res. 2012 Mar;35(4):717-22.
molnova catalog
related products
-
Baohuoside V
Baohuoside V is a natural product.
-
Levothyroxine sodium
Levothyroxine, the major hormone derived from the thyroid gland, is the agonist of Thyroid hormone receptor alpha and beta.evothyroxine (L-T(4))can upregulate the expression of P-gp mRNA and protein in LS180 cells, but only L-T(4) and L-T(3) can produce the same effect in Caco-2 cells, which are relatively lacking in PXR.
-
TD-198946
TD-198946, a potent chondrogenic agent, is a thienoindazole derivative.